v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating Expenses [Abstract]        
Research and development $ 1,249 $ 502 $ 2,515 $ 689
General and administrative 2,975 497 6,285 975
Total operating expenses 4,224 999 8,800 1,664
Loss from operations (4,224) (999) (8,800) (1,664)
Other expense:        
Interest expense (123) 0 (123) 0
Total other expense (123) 0 (123) 0
Net loss and comprehensive loss $ (4,347) $ (999) $ (8,923) $ (1,664)
Net loss per share, basic $ (0.02) $ (0.01) $ (0.04) $ (0.01)
Net loss per share, diluted $ (0.02) $ (0.01) $ (0.04) $ (0.01)
Weighted average shares of common stock outstanding, basic 230,209,142 200,000,000 230,209,142 200,000,000
Weighted average shares of common stock outstanding, diluted 230,209,142 200,000,000 230,209,142 200,000,000